New in MMWR: Mpox Vaccine Effectiveness, Disability by Occupation, and more

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

MMWR banner

May 19, 2023


The figure is a graphic with text explaining how two doses of the JYNNEOS vaccine is effective in preventing mpox.

Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023

In this study, adjusted vaccine effectiveness was 75% for 1 dose and 86% for 2 doses of JYNNEOS vaccine, indicating substantial protection against mpox, irrespective of route of administration or immunocompromise status.


The figure is a bar chart showing percentage of children and adolescents aged 5–17 years who received free or reduced-cost meals at school during the previous 12 months in 2021 in the United States, by race and Hispanic ethnicity and family income, according to the National Health Interview Survey.

PDF of this Issue (link).


The figure is a photo of a doctor writing on a clipboard while sitting across from a patient.


This figure is an image of a microphone on a dark background with sound waves and the text “MMWR Weekly Briefing,” representing the MMWR podcast.

MMWR Weekly Briefing Podcast: Week of May 8

The latest MMWR Weekly Briefing is live. Topics include: changes in emergency department visits among adolescents, cases of severe ringworm in New York City, and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 

[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux